Ursolic Acid Inhibits Collective Cell Migration and Promotes JNK-Dependent Lysosomal Associated Cell Death in Glioblastoma Multiforme Cells

Abstract

Ursolic acid (UA) is a bioactive compound which has demonstrated therapeutic efficacy in a variety of cancer cell lines. UA activates various signalling pathways in Glioblastoma multiforme (GBM) and offers a promising starting point in drug discovery; however, understanding the relationship between cell death and migration has yet to be elucidated. UA induces a dose dependent cytotoxic response demonstrated by flow cytometry and biochemical cytotoxicity assays. Inhibitor and fluorescent probe studies demonstrate that UA induces a caspase independent, JNK dependent, mechanism of cell death. Migration studies established that UA inhibits GBM collective cell migration in a time dependent manner that is independent of the JNK signalling pathway. Cytotoxicity induced by UA results in the formation of acidic vesicle organelles (AVOs), speculating the activation of autophagy. However, inhibitor and spectrophotometric analysis demonstrated that autophagy was not responsible for the formation of the AVOs. Confocal microscopy and isosurface visualisation determined co-localisation of lysosomes with the previously identified AVOs, thus providing evidence that lysosomes are likely to be playing a role in UA induced cell death. Collectively, our data identify that UA rapidly induces a lysosomal associated mechanism of cell death in addition to UA acting as an inhibitor of GBM collective cell migration. https://doi.org/10.13039/5011000033295https://doi.org/10.13039/5011000033293https://doi.org/10.13039/5011000033296https://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329_https://doi.org/10.13039/501100003329_https://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329 $h ttps://doi.org/10.13039/501100003329ahttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329Mhttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329nhttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329shttps://doi.org/10.13039/501100003329thttps://doi.org/10.13039/501100003329ehttps://doi.org/10.13039/501100003329rhttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329ohttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329dhttps://doi.org/10.13039/501100003329ehttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329Ehttps://doi.org/10.13039/501100003329chttps://doi.org/10.13039/501100003329ohttps://doi.org/10.13039/501100003329nhttps://doi.org/10.13039/501100003329ohttps://doi.org/10.13039/501100003329mhttps://doi.org/10.13039/501100003329íhttps://doi.org/10.13039/501100003329ahttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329yhttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329Chttps://doi.org/10.13039/501100003329ohttps://doi.org/10.13039/501100003329mhttps://doi.org/10.13039/501100003329phttps://doi.org/10.13039/501100003329ehttps://doi.org/10.13039/501100003329thttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329thttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329vhttps://doi.org/10.13039/501100003329ihttps://doi.org/10.13039/501100003329dhttps://doi.org/10.13039/501100003329ahttps://doi.org/10.13039/501100003329dhttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329 $h ttps://doi.org/10.13039/501100003329dhttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329 $h ttps://doi.org/10.13039/501100003329fhttps://doi.org/10.13039/501100003329 https://doi.org/10.13039/501100003329Shttps://doi.org/10.13039/501100003329Ahttps://doi.org/10.13039/501100003329Fhttps://doi.org/10.13039/5011000033292https://doi.org/10.13039/5011000033290https://doi.org/10.13039/5011000033291https://doi.org/10.13039/5011000033295https://doi.org/10.13039/501100003329-https://doi.org/10.13039/5011000033296https://doi.org/10.13039/5011000033294https://doi.org/10.13039/5011000033291https://doi.org/10.13039/5011000033292https://doi.org/10.13039/5011000033293https://doi.org/10.13039/501100003329-https://doi.org/10.13039/501100003329Phttps://doi.org/10.13039/501100003329

Document Type

Article

Language

English

Publisher

 

Related items

Pharmaceuticals ; Vol. 14 (january 2021)

Recommended citation

This citation was generated automatically.

Rights

open access

Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.

https://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)